{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:23:39Z","timestamp":1793651019869,"version":"4.5.1"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,9,27]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The benefit of high-flow nasal cannula oxygen (high-flow oxygen) in terms of intubation and mortality in patients with respiratory failure due to COVID-19 is controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether the use of high-flow oxygen, compared with standard oxygen, could reduce the rate of mortality at day 28 in patients with respiratory failure due to COVID-19 admitted in intensive care units (ICUs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>The SOHO-COVID randomized clinical trial was conducted in 34 ICUs in France and included 711 patients with respiratory failure due to COVID-19 and a ratio of partial pressure of arterial oxygen to fraction of inspired oxygen equal to or below 200 mm Hg. It was an ancillary trial of the ongoing original SOHO randomized clinical trial, which was designed to include patients with acute hypoxemic respiratory failure from all causes. Patients were enrolled from January to December 2021; final follow-up occurred on March 5, 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Patients were randomly assigned to receive high-flow oxygen (n\u2009=\u2009357) or standard oxygen delivered through a nonrebreathing mask initially set at a 10-L\/min minimum (n\u2009=\u2009354).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was mortality at day 28. There were 13 secondary outcomes, including the proportion of patients requiring intubation, number of ventilator-free days at day 28, mortality at day 90, mortality and length of stay in the ICU, and adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 782 randomized patients, 711 patients with respiratory failure due to COVID-19 were included in the analysis (mean [SD] age, 61 [12] years; 214 women [30%]). The mortality rate at day 28 was 10% (36\/357) with high-flow oxygen and 11% (40\/354) with standard oxygen (absolute difference, \u20131.2% [95% CI, \u20135.8% to 3.4%];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.60). Of 13 prespecified secondary outcomes, 12 showed no significant difference including in length of stay and mortality in the ICU and in mortality up until day 90. The intubation rate was significantly lower with high-flow oxygen than with standard oxygen (45% [160\/357] vs 53% [186\/354]; absolute difference, \u20137.7% [95% CI, \u201314.9% to \u20130.4%];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.04). The number of ventilator-free days at day 28 was not significantly different between groups (median, 28 [IQR, 11-28] vs 23 [IQR, 10-28] days; absolute difference, 0.5 days [95% CI, \u20137.7 to 9.1];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.07). The most common adverse events were ventilator-associated pneumonia, occurring in 58% (93\/160) in the high-flow oxygen group and 53% (99\/186) in the standard oxygen group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Among patients with respiratory failure due to COVID-19, high-flow nasal cannula oxygen, compared with standard oxygen therapy, did not significantly reduce 28-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04468126\">NCT04468126<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2022.15613","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:06:10Z","timestamp":1664276770000},"page":"1212","source":"Crossref","is-referenced-by-count":128,"title":["Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19"],"prefix":"10.1001","volume":"328","author":[{"given":"Jean-Pierre","family":"Frat","sequence":"first","affiliation":[{"name":"CHU de Poitiers, M\u00e9decine Intensive R\u00e9animation, Poitiers, France"},{"name":"INSERM, CIC-1402, ALIVE, Poitiers, France; Universit\u00e9 de Poitiers, Facult\u00e9 de M\u00e9decine et de Pharmacie de Poitiers, Poitiers, France"},{"name":"CRICS-TriggerSEP F-CRIN Research Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Quenot","sequence":"additional","affiliation":[{"name":"CHU Dijon-Bourgogne, M\u00e9decine Intensive-R\u00e9animation, Dijon, France"},{"name":"Equipe Lipness, Centre de Recherche INSERM UMR1231 et LabEx LipSTIC, Universit\u00e9 de Bourgogne-Franche Comt\u00e9, Dijon, France"},{"name":"INSERM, CIC 1432, Module \u00c9pid\u00e9miologie Clinique, Universit\u00e9 de Bourgogne-Franche Comt\u00e9, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Badie","sequence":"additional","affiliation":[{"name":"Hopital Nord Franche-Comte, Montbeliard, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Coudroy","sequence":"additional","affiliation":[{"name":"CHU de Poitiers, M\u00e9decine Intensive R\u00e9animation, Poitiers, France"},{"name":"INSERM, CIC-1402, ALIVE, Poitiers, France; Universit\u00e9 de Poitiers, Facult\u00e9 de M\u00e9decine et de Pharmacie de Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Guitton","sequence":"additional","affiliation":[{"name":"CH du Mans, R\u00e9animation M\u00e9dico-Chirurgicale, Le Mans, France"},{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 d\u2019Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehrmann","sequence":"additional","affiliation":[{"name":"CHRU Tours, M\u00e9decine Intensive R\u00e9animation, Tours, France"},{"name":"CIC INSERM 1415, Universit\u00e9 de Tours, Tours, France"},{"name":"CRICS-TriggerSEP F-CRIN Research Network"},{"name":"Centre d\u2019\u00e9tude des Pathologies Respiratoires, INSERM U1100, Universit\u00e9 de Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Gacouin","sequence":"additional","affiliation":[{"name":"CHU de Rennes, H\u00f4pital Pontchaillou, Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Merdji","sequence":"additional","affiliation":[{"name":"H\u00f4pitaux Universitaires de Strasbourg, Nouvel H\u00f4pital Civil, M\u00e9decine Intensive-R\u00e9animation, Strasbourg, France"},{"name":"Universit\u00e9 Strasbourg (UNISTRA), Facult\u00e9 de M\u00e9decine, INSERM UMR 1260, Regenerative Nanomedecine, FMTS, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Auchabie","sequence":"additional","affiliation":[{"name":"CH de Cholet, Service de R\u00e9animation Polyvalente, Cholet, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Daubin","sequence":"additional","affiliation":[{"name":"CHU de Caen, M\u00e9decine Intensive R\u00e9animation, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Florence","family":"Dureau","sequence":"additional","affiliation":[{"name":"GHR Mulhouse Sud-Alsace, M\u00e9decine Intensive R\u00e9animation, Mulhouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Thibault","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Sud de la R\u00e9union, M\u00e9decine Intensive R\u00e9animation, Saint Pierre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Sedillot","sequence":"additional","affiliation":[{"name":"CH de Bourg-en-Bresse, Service de R\u00e9animation, Bourg-en-Bresse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Rigaud","sequence":"additional","affiliation":[{"name":"CH de Dieppe, M\u00e9decine Intensive R\u00e9animation, Dieppe, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Demoule","sequence":"additional","affiliation":[{"name":"AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, site Piti\u00e9-Salp\u00eatri\u00e8re, M\u00e9decine Intensive et R\u00e9animation (D\u00e9partement R3S) and Sorbonne Universit\u00e9, Paris, France"},{"name":"INSERM, UMRS1158 Neurophysiologie Respiratoire Exp\u00e9rimentale et Clinique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhamid","family":"Fatah","sequence":"additional","affiliation":[{"name":"Groupement Hospitalier Nord-Dauphin\u00e9, Service de R\u00e9animation, Bourgoin-Jallieu, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Terzi","sequence":"additional","affiliation":[{"name":"CHU Grenoble Alpes, M\u00e9decine Intensive R\u00e9animation, Grenoble, France"},{"name":"INSERM, Universit\u00e9 Grenoble-Alpes, U1042, HP2, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Simonin","sequence":"additional","affiliation":[{"name":"H\u00f4pital Saint-Joseph Saint-Luc, R\u00e9animation Polyvalente, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Danjou","sequence":"additional","affiliation":[{"name":"CHU La Croix Rousse, Hospices civils de Lyon, M\u00e9decine Intensive R\u00e9animation, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Carteaux","sequence":"additional","affiliation":[{"name":"AP-HP, CHU Henri Mondor, M\u00e9decine Intensive R\u00e9animation, Cr\u00e9teil, France"},{"name":"Universit\u00e9 Paris Est Cr\u00e9teil, Facult\u00e9 de Sant\u00e9, Groupe de Recherche Clinique CARMAS, Cr\u00e9teil, France"},{"name":"INSERM, Unit\u00e9 UMR 955, IMRB, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Guesdon","sequence":"additional","affiliation":[{"name":"CH de Pau, R\u00e9animation polyvalente, Pau, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Pradel","sequence":"additional","affiliation":[{"name":"CH Henri Mondor d\u2019Aurillac, Service de R\u00e9animation, Aurillac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Catherine","family":"Besse","sequence":"additional","affiliation":[{"name":"CH de Bourges, R\u00e9animation polyvalente, Bourges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[{"name":"CHU de Nantes, M\u00e9decine Intensive R\u00e9animation, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Beloncle","sequence":"additional","affiliation":[{"name":"CHU d'Angers, D\u00e9partement de M\u00e9decine Intensive\u2013R\u00e9animation et M\u00e9decine Hyperbare, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"La Combe","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Bretagne Sud, Service de R\u00e9animation polyvalente, Lorient, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gw\u00e9na\u00ebl","family":"Prat","sequence":"additional","affiliation":[{"name":"CHU de Brest, M\u00e9decine Intensive R\u00e9animation, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai-Anh","family":"Nay","sequence":"additional","affiliation":[{"name":"CHR d'Orl\u00e9ans, M\u00e9decine Intensive R\u00e9animation, Orl\u00e9ans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"de Keizer","sequence":"additional","affiliation":[{"name":"INSERM, CIC-1402, Poitiers, France; Universit\u00e9 de Poitiers, Facult\u00e9 de M\u00e9decine et de Pharmacie de Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ragot","sequence":"additional","affiliation":[{"name":"INSERM, CIC-1402, Poitiers, France; Universit\u00e9 de Poitiers, Facult\u00e9 de M\u00e9decine et de Pharmacie de Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud W.","family":"Thille","sequence":"additional","affiliation":[{"name":"CHU de Poitiers, M\u00e9decine Intensive R\u00e9animation, Poitiers, France"},{"name":"INSERM, CIC-1402, ALIVE, Poitiers, France; Universit\u00e9 de Poitiers, Facult\u00e9 de M\u00e9decine et de Pharmacie de Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SOHO-COVID Study Group and the REVA Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeva","family":"RODRIGUEZ","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"ARRIVE","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"VEINSTEIN","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"CHATELLIER","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"LEPAPE","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"BOISSIER","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"JACQUIER","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"LABRUYERE","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"BERDAGUER","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"MALFROY","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaouki","family":"MEZHER","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"CHUDEAU","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micka\u00ebl","family":"LANDAIS","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"DARREAU","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"BODET CONTENTIN","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"JACQUIER","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"GAROT","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"DELAMAIRE","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"MAAMAR","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"PAINVIN","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"HELMS","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"DEMISELLE","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"JAROUSSEAU","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"LE MEUR","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"JORET","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Du CHEYRON","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"OUDEVILLE","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"POINTURIER","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"ANTOK","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"MOUREMBLES","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"SALADIN","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"BIGOT","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00f4me","family":"BUREAU","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"DELERIS","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nga","family":"PHAN","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"LEDOCHOWSKI","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis Marie","family":"GALERNEAU","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"DARTEVEL","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"BOURDIN","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"VIVIER","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"DHELFT","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"MEKONTSO DESSAP","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"DESTIZONS","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"THEILLAUD","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"BLONZ","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"ASFAR","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"CAILLIEZ","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"BAILLY","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"BRETAGNOL","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"CONTOU","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"DELBOVE","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"LAUTRETTE","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"NIGEON","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Paul","family":"MIRA","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"SBOUI","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"SACCHERI","sequence":"additional","affiliation":[{"name":"for the SOHO-COVID Study Group and the REVA Network"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1137","key":"joi220096r2","doi-asserted-by":"publisher","first-page":"n1137","DOI":"10.1136\/bmj.n1137","article-title":"Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries.","volume":"373","author":"Islam","year":"2021","journal-title":"BMJ"},{"issue":"16","key":"joi220096r3","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy.","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"joi220096r4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","article-title":"Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.","volume":"47","author":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators","year":"2021","journal-title":"Intensive Care Med"},{"issue":"10239","key":"joi220096r5","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"joi220096r6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jama.2021.24868","article-title":"Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves.","volume":"327","author":"Maslo","year":"2022","journal-title":"JAMA"},{"issue":"7","key":"joi220096r7","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1164\/rccm.202005-2007LE","article-title":"High-flow nasal cannula in critically ill patients with severe COVID-19.","volume":"202","author":"Demoule","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"joi220096r8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13613-021-00825-5","article-title":"High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study.","volume":"11","author":"Bonnet","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"5","key":"joi220096r9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02130-2020","article-title":"Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia.","volume":"56","author":"Franco","year":"2020","journal-title":"Eur Respir J"},{"issue":"17","key":"joi220096r10","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/jama.2021.4682","article-title":"Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial.","volume":"325","author":"Grieco","year":"2021","journal-title":"JAMA"},{"issue":"21","key":"joi220096r11","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1001\/jama.2021.20714","article-title":"Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial.","volume":"326","author":"Ospina-Tasc\u00f3n","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"joi220096r12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/jama.2022.0028","article-title":"Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial.","volume":"327","author":"Perkins","year":"2022","journal-title":"JAMA"},{"issue":"23","key":"joi220096r13","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"issue":"20","key":"joi220096r14","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1001\/jama.2018.14282","article-title":"Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial.","volume":"320","author":"Azoulay","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"joi220096r15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1164\/rccm.202006-2157CP","article-title":"Why COVID-19 silent hypoxemia is baffling to physicians.","volume":"202","author":"Tobin","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"joi220096r16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1513\/AnnalsATS.202011-1376CME","article-title":"The pathophysiology and dangers of silent hypoxemia in COVID-19 lung injury.","volume":"18","author":"Swenson","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"joi220096r17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/thoraxjnl-2020-214863","article-title":"Reliability of methods to estimate the fraction of inspired oxygen in patients with acute respiratory failure breathing through non-rebreather reservoir bag oxygen mask.","volume":"75","author":"Coudroy","year":"2020","journal-title":"Thorax"},{"issue":"1","key":"joi220096r18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13613-019-0578-8","article-title":"Predictors of successful separation from high-flow nasal oxygen therapy in patients with acute respiratory failure: a retrospective monocenter study.","volume":"9","author":"Rodriguez","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"11","key":"joi220096r19","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1097\/CCM.0000000000004600","article-title":"Timing of intubation and mortality among critically ill coronavirus disease 2019 patients: a single-center cohort study.","volume":"48","author":"Hernandez-Romieu","year":"2020","journal-title":"Crit Care Med"},{"issue":"1","key":"joi220096r20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000650","article-title":"Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.","volume":"7","author":"Patel","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"6","key":"joi220096r21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/jama.2022.0028","article-title":"Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial.","volume":"327","author":"Perkins","year":"2022","journal-title":"JAMA"},{"issue":"13","key":"joi220096r22","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis.","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"joi220096r23","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1164\/rccm.201605-0916OC","article-title":"Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure.","volume":"195","author":"Mauri","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"joi220096r24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1152\/japplphysiol.00584.2016","article-title":"Nasal high flow reduces dead space.","volume":"122","author":"M\u00f6ller","year":"2017","journal-title":"J Appl Physiol (1985)"},{"key":"joi220096r1","unstructured":"World Health Organization. WHO coronavirus (COVID-19) dashboard. Accessed January 12, 2022. https:\/\/covid19.who.int"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2796693\/jama_frat_2022_oi_220096_1664218840.19107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:06:14Z","timestamp":1664276774000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2796693"}},"subtitle":["The SOHO-COVID Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,9,27]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.15613","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}